These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16892225

  • 21. Discovery of a class of diketopiperazines as antiprion compounds.
    Bolognesi ML, Ai Tran HN, Staderini M, Monaco A, López-Cobeñas A, Bongarzone S, Biarnés X, López-Alvarado P, Cabezas N, Caramelli M, Carloni P, Menéndez JC, Legname G.
    ChemMedChem; 2010 Aug 02; 5(8):1324-34. PubMed ID: 20540064
    [Abstract] [Full Text] [Related]

  • 22. Development of a novel yeast cell-based system for studying the aggregation of Alzheimer's disease-associated Abeta peptides in vivo.
    von der Haar T, Jossé L, Wright P, Zenthon J, Tuite MF.
    Neurodegener Dis; 2007 Aug 02; 4(2-3):136-47. PubMed ID: 17596708
    [Abstract] [Full Text] [Related]

  • 23. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
    Catharino S, Buchner J, Walter S.
    Biol Chem; 2005 Jul 02; 386(7):633-41. PubMed ID: 16207084
    [Abstract] [Full Text] [Related]

  • 24. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
    Outeiro TF, Giorgini F.
    Biotechnol J; 2006 Mar 02; 1(3):258-69. PubMed ID: 16897706
    [Abstract] [Full Text] [Related]

  • 25. Prion: disease or relief?
    Chernoff YO.
    Nat Cell Biol; 2008 Sep 02; 10(9):1019-21. PubMed ID: 18758490
    [Abstract] [Full Text] [Related]

  • 26. Identifying Anti-prion Chemical Compounds Using a Newly Established Yeast High-Throughput Screening System.
    Du Z, Valtierra S, Cardona LR, Dunne SF, Luan CH, Li L.
    Cell Chem Biol; 2019 Dec 19; 26(12):1664-1680.e4. PubMed ID: 31668517
    [Abstract] [Full Text] [Related]

  • 27. [Final proof of "prion hypothesis" in the yeast prion [PSI+] system].
    Tanaka M.
    Tanpakushitsu Kakusan Koso; 2005 Mar 19; 50(3):207-14. PubMed ID: 15773301
    [No Abstract] [Full Text] [Related]

  • 28. [Estimating of changes in the amyloid and prion content of yeast cells].
    Nevzgliadova OV, Kuznetsova IM, Artemov AV, Mikhaĭlova EV, Turoverov KK, Soĭdla TR.
    Tsitologiia; 2008 Mar 19; 50(1):40-8. PubMed ID: 18409367
    [Abstract] [Full Text] [Related]

  • 29. In vitro assay for fragmentation of amyloid fibers of yeast prion protein.
    Inoue Y, Yoshida M.
    Methods; 2006 May 19; 39(1):56-60. PubMed ID: 16750392
    [Abstract] [Full Text] [Related]

  • 30. Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast.
    Alberti S, Halfmann R, Lindquist S.
    Methods Enzymol; 2010 May 19; 470():709-34. PubMed ID: 20946833
    [Abstract] [Full Text] [Related]

  • 31. Prion species barrier between the closely related yeast proteins is detected despite coaggregation.
    Chen B, Newnam GP, Chernoff YO.
    Proc Natl Acad Sci U S A; 2007 Feb 20; 104(8):2791-6. PubMed ID: 17296932
    [Abstract] [Full Text] [Related]

  • 32. Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds?
    Caughey B, Caughey WS, Kocisko DA, Lee KS, Silveira JR, Morrey JD.
    Acc Chem Res; 2006 Sep 20; 39(9):646-53. PubMed ID: 16981681
    [Abstract] [Full Text] [Related]

  • 33. Anti-prion drug screening system in Saccharomyces cerevisiae based on an artificial [LEU2+] prion.
    Ishikawa T, Lisiecki K.
    Fungal Genet Biol; 2020 Jan 20; 134():103280. PubMed ID: 31622671
    [Abstract] [Full Text] [Related]

  • 34. Prions as adaptive conduits of memory and inheritance.
    Shorter J, Lindquist S.
    Nat Rev Genet; 2005 Jun 20; 6(6):435-50. PubMed ID: 15931169
    [Abstract] [Full Text] [Related]

  • 35. Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models.
    Voisset C, Saupe SJ, Galons H, Blondel M.
    Infect Disord Drug Targets; 2009 Feb 20; 9(1):31-9. PubMed ID: 19200013
    [Abstract] [Full Text] [Related]

  • 36. Yeast-based screening of natural product extracts results in the identification of prion inhibitors from a marine sponge.
    Jennings LK, Ahmed I, Munn AL, Carroll AR.
    Prion; 2018 Feb 20; 12(3-4):234-244. PubMed ID: 30165789
    [Abstract] [Full Text] [Related]

  • 37. Clearance of yeast prions by misfolded multi-transmembrane proteins.
    Arai C, Kurahashi H, Ishiwata M, Oishi K, Nakamura Y.
    Biochimie; 2013 Jun 20; 95(6):1223-32. PubMed ID: 23384482
    [Abstract] [Full Text] [Related]

  • 38. Investigating protein conformation-based inheritance and disease in yeast.
    Lindquist S, Krobitsch S, Li L, Sondheimer N.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):169-76. PubMed ID: 11260797
    [Abstract] [Full Text] [Related]

  • 39. Generation of genuine prion infectivity by serial PMCA.
    Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, Kretzschmar HA.
    Vet Microbiol; 2007 Aug 31; 123(4):346-57. PubMed ID: 17493773
    [Abstract] [Full Text] [Related]

  • 40. Saccharomyces cerevisiae in neuroscience: how unicellular organism helps to better understand prion protein?
    Ishikawa T.
    Neural Regen Res; 2021 Mar 31; 16(3):489-495. PubMed ID: 32985470
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.